Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Elise Konradsson"'
Autor:
Bolette W. Gjaldbæk, Maja L. Arendt, Elise Konradsson, Kristine Bastholm Jensen, Sven Å. J. Bäck, Per Munck af Rosenschöld, Crister Ceberg, Kristoffer Petersson, Betina Børresen
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionFLASH radiotherapy (RT) has emerged as a promising modality, demonstrating both a normal tissue sparing effect and anticancer efficacy. We have previously reported on the safety and efficacy of single fraction FLASH RT in the treatment of
Externí odkaz:
https://doaj.org/article/b2120e1b818e429fa60fa36575af12e1
Autor:
Elise Konradsson, Pontus Wahlqvist, Andreas Thoft, Börje Blad, Sven Bäck, Crister Ceberg, Kristoffer Petersson
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionWe have previously adapted a clinical linear accelerator (Elekta Precise, Elekta AB) for ultra-high dose rate (UHDR) electron delivery. To enhance reliability in future clinical FLASH radiotherapy trials, the aim of this study was to intr
Externí odkaz:
https://doaj.org/article/1b7f3fc19d6e4e6aac48fa1f169a92f6
Autor:
Emma Liljedahl, Elise Konradsson, Karin Linderfalk, Emma Gustafsson, Kristoffer Petersson, Crister Ceberg, Henrietta Nittby Redebrandt
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundRadiotherapy increases survival in patients with glioblastoma. However, the prescribed dose is limited by unwanted side effects on normal tissue. Previous experimental studies have shown that FLASH radiotherapy (FLASH-RT) can reduce these s
Externí odkaz:
https://doaj.org/article/47c7575fea414a93bf023e157e2e6f72
Autor:
Betina Børresen, Maja L. Arendt, Elise Konradsson, Kristine Bastholm Jensen, Sven ÅJ. Bäck, Per Munck af Rosenschöld, Crister Ceberg, Kristoffer Petersson
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundFLASH radiotherapy (RT) is a novel method for delivering ionizing radiation, which has been shown in preclinical studies to have a normal tissue sparing effect and to maintain anticancer efficacy as compared to conventional RT. Treatment of
Externí odkaz:
https://doaj.org/article/98da175dc7d74a7b9d3b581169f61e4a
Autor:
Emma Liljedahl, Elise Konradsson, Emma Gustafsson, Karolina Förnvik Jonsson, Jill K. Olofsson, Kurt Osther, Crister Ceberg, Henrietta Nittby Redebrandt
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background A more effective immune response against glioblastoma is needed in order to achieve better tumor control. Radiotherapy can induce anti-tumor mediated immune reactions, in addition to its dose response effects. The complement syste
Externí odkaz:
https://doaj.org/article/3e18c7a729e44f138f7a6fd6275fefb7
Autor:
Emma Liljedahl, Elise Konradsson, Emma Gustafsson, Karolina Förnvik Jonsson, Jill K. Olofsson, Crister Ceberg, Henrietta Nittby Redebrandt
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Radiotherapy can induce an immunological response. One limiting factor is side effects on normal tissue. Using FLASH radiotherapy, side effects could possibly be reduced. The efficacy of FLASH in relation to conventional radiotherapy (CONV-R
Externí odkaz:
https://doaj.org/article/3e1c8891f52d431d89a9fe69b91e9653
Autor:
Elise Konradsson, MSc, Emma Liljedahl, MD, Emma Gustafsson, MSc, Gabriel Adrian, MD, PhD, Sarah Beyer, MSc, Suhayb Ehsaan Ilaahi, MSc, Kristoffer Petersson, PhD, Crister Ceberg, PhD, Henrietta Nittby Redebrandt, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101011- (2022)
Purpose: To ensure a clinical translation of FLASH radiation therapy (FLASH-RT) for a specific tumor type, studies on tumor control and toxicity within the same biological system are needed. In this study, our objective was to evaluate tumor control
Externí odkaz:
https://doaj.org/article/55e88a8a575942d39a360fd1205610ad
Autor:
Gabriel Adrian, Elise Konradsson, Sarah Beyer, Anders Wittrup, Karl T. Butterworth, Stephen J. McMahon, Mihaela Ghita, Kristoffer Petersson, Crister Ceberg
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundIrradiation with ultra-high dose rate (FLASH) has been shown to spare normal tissue without hampering tumor control in several in vivo studies. Few cell lines have been investigated in vitro, and previous results are inconsistent. Assuming
Externí odkaz:
https://doaj.org/article/469e2113cafa4b189229e664a90ccba4
Autor:
Elise Konradsson, Maja L. Arendt, Kristine Bastholm Jensen, Betina Børresen, Anders E. Hansen, Sven Bäck, Annemarie T. Kristensen, Per Munck af Rosenschöld, Crister Ceberg, Kristoffer Petersson
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
FLASH radiotherapy has emerged as a treatment technique with great potential to increase the differential effect between normal tissue toxicity and tumor response compared to conventional radiotherapy. To evaluate the feasibility of FLASH radiotherap
Externí odkaz:
https://doaj.org/article/df18f26929944fe6885a4c197de5e0e6
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233617 (2020)
OBJECTIVES:The aim of the study was to investigate therapeutic efficacy of single- or two-fraction radiotherapy in conjunction with IDO1-inhibition in a syngeneic rat glioblastoma model. IDO is known to cause immunosuppression through breakdown of tr
Externí odkaz:
https://doaj.org/article/a663c4dfe3ec4e4899903edc11230cb6